alexa HER2 Protein Biomarker Based Sensor Systems

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

HER2 Protein Biomarker Based Sensor Systems

Human Epidermal Growth Factor Receptor 2 (HER2) is overexpressed in breast cancers and is a key predictive biomarker and an effective therapeutic treatment target for breast cancer. The vast evidence from various studies indicates that patients with HER2-positive breast cancer have a poorer prognosis than patients with HER2-negative breast cancer, and it requires a extraordinary therapy. Therefore, identifying the overexpression of HER2 for breast cancer diagnosis and therapy is very important. In recent years, several methods for detecting HER2-positive cancer cells have been developed, which include genomic and proteomic assays, optical assays, fluorescence, scattering assays, direct cell imaging. 

Citation: Chandra P, Suman P, Mukherjee M, Kumar P (2013) HER2 Protein Biomarker Based Sensor Systems for Breast Cancer Diagnosis. J Mol Biomark Diagn 5:e119. 

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger